Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
0.469
-0.013 (-2.61%)
At close: Apr 12, 2024, 4:00 PM
0.462
-0.008 (-1.66%)
After-hours: Apr 12, 2024, 5:36 PM EDT

Daré Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
2.811000000000.08
Upgrade
Revenue Growth (YoY)
-71.92%--------1233.33%
Upgrade
Gross Profit
2.811000000000.08
Upgrade
Selling, General & Admin
12.1111.248.356.555.274.662.70.1611.228.59
Upgrade
Research & Development
21.5430.0430.6220.778.556.410.980.0725.9511.77
Upgrade
Other Operating Expenses
0.10.10.10.080.535.817.490.400
Upgrade
Operating Expenses
33.7541.3939.0727.414.3416.8811.180.6337.1720.36
Upgrade
Operating Income
-30.94-31.39-39.07-27.4-14.34-16.88-11.18-0.63-37.17-20.28
Upgrade
Interest Expense / Income
00000000.042.431.08
Upgrade
Other Expense / Income
-0.78-0.44-0.37-0-0.08-0.140.32--0.011.98
Upgrade
Pretax Income
-30.16-30.95-38.7-27.4-14.26-16.74-11.5-0.67-39.59-23.34
Upgrade
Net Income
-30.16-30.95-38.7-27.4-14.26-16.74-11.5-0.67-39.59-23.34
Upgrade
Preferred Dividends
0000.010.7900000
Upgrade
Net Income Common
-30.16-30.95-38.7-27.41-15.05-16.74-11.5-0.67-39.59-23.34
Upgrade
Shares Outstanding (Basic)
8785613016113131
Upgrade
Shares Outstanding (Diluted)
8785613016113131
Upgrade
Shares Change
3.23%38.29%103.23%93.15%45.16%232.04%287.10%-67.17%74.80%2025.95%
Upgrade
EPS (Basic)
-0.35-0.37-0.63-0.91-0.97-1.57-3.56-0.81-15.60-16.00
Upgrade
EPS (Diluted)
-0.35-0.37-0.63-0.91-0.97-1.57-3.56-0.81-15.60-16.00
Upgrade
Free Cash Flow
-39.49-18.15-28.78-25.25-13.32-10.28-2.54-0.37-32.17-19.25
Upgrade
Free Cash Flow Per Share
-0.45-0.21-0.47-0.84-0.85-0.96-0.79-0.45-12.65-13.23
Upgrade
Gross Margin
100.00%100.00%-------100.00%
Upgrade
Operating Margin
-1101.89%-313.85%--------25348.75%
Upgrade
Profit Margin
-1074.17%-309.48%--------29177.50%
Upgrade
Free Cash Flow Margin
-1406.26%-181.51%--------24057.50%
Upgrade
EBITDA
-30.07-30.9-38.77-27.52-14.28-16.73-11.5-0.63-36.97-22.13
Upgrade
EBITDA Margin
-1070.88%-309.00%--------27666.25%
Upgrade
Depreciation & Amortization
0.090.05-0.07-0.12-0.020.01000.190.13
Upgrade
EBIT
-30.16-30.95-38.7-27.4-14.26-16.74-11.5-0.63-37.16-22.26
Upgrade
EBIT Margin
-1074.17%-309.48%--------27823.75%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).